Waarde capital | index
Description: Inflamalps is a biopharmaceutical company established in Valais, Switzerland
company (8793) switzerland (2868) valais (982) biopharmaceutical (54) blockers (7) inflamalps (1) inf101 (1) tnfr1 (1)
Inflamalps is a biopharmaceutical company established in Valais, Switzerland. Inflamalps’ mission is to discover anti-inflammatory and anti-microbial new molecules. Inflamalps is developing INF101 for the treatment of dry eye in ophthalmology. Since 2020, Inflamalps is leading a drug discovery effort to discover novel anti-microbial molecules in partnership with the University of Turin in Italy, the University of Canterbury in New-Zealand, the Haute Ecole d’ingénierie et d'architecture de Fribourg in Switze
Waarde capital | index